Biggest News Aggregation in the World
📰 Clinical Application News

Page 9 - Clinical Application News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Clinical Application. Real-time updates on events, politics, business and more.

Enhanced muscle regeneration using stem cells

Kyoto University The Hidetoshi Sakurai laboratory reports two new markers that should advance iPS cell therapies for muscle degeneration. Muscular dystrophy describes a group of muscle degenerative congenital diseases. The severity and rates differ between disease and patient, but in all cases the degeneration progresses, sometimes leaving patients in wheelchairs and unable to breathe without artificial respiration. With no present cure, scientists are experimenting with the transplan...
Mingming Zhao Akitsu Hotta Naoshi Sugimoto Antonio Lucena Cacace Tatsuya Jonouchi Hidetoshi Sakurai

A simple step to enhance CRISPR-Cas9 genome editing

Kyoto University The Hotta lab shows that protection from cellular RNA enhances the genome editing of iPS cells. The ability for scientists to edit human genomic DNA has been around for decades. Such research has revealed how a single mutation in just one of the billions of base pairs in the human genome can cause destructive diseases. In the past decade, advances in CRISPR-Cas9 technology have taken DNA editing a major step farther and promise to revolutionize regenerative medicine. One of t...
Takahiro Iguchi Peter Gee Miyuki Ono Akitsu Hotta Yuto Kita Huaigeng Xu

Fluvoxamine Market: Global Industry Growth, Market Size, Market Share and Forecast 2020-2027 – Business

The global fluvoxamine market size was valued at USD 592 million in 2020 and projected to grow at a significant CAGR of 3% during the forecast period 2021 to 2027. The rising prevalence of anxiety and depression across the globe is a major factor to drive the market growth. Moreover, the increasing incidence of social anxiety disorder is expected to propel the market growth over the forecast period. The global fluvoxamine market is bifurcated into clinical application, distribution channel, an...
United States South Africa Vijendra Singh Asia Pacific Baypharma Gmb Fluvoxamine Marketreport

Hemodialysis Blood Tubing Set Market Segmentation, Forecast, Analysis, Industry Size and Share to 2027 – Business

The global hemodialysis blood tubing sets market size was valued at USD 1,733 million in 2020 and anticipated to register a significant CAGR of 5.2% during the forecast period 2021 to 2027 and expected to reach around USD 2.5 billion by 2027. The increasing prevalence of end-stage renal disease is a major factor to drive the market growth. Moreover, the increasing incidence of acid-base and electrolyte imbalance in patients suffering from chronic kidney disease is supporting the market growth....
United States South Africa Vijendra Singh Asia Pacific Fresenius Kabi Renax Biomedical Technology Co Ltd

Worldwide Liquid Biopsy Industry to 2026 - Players Include Thermo Fisher Scientific, Roche Diagnostics and Biocept Among Others

Share this article Share this article ResearchAndMarkets.coms offering. This report provides a detailed analysis of Global Liquid Biopsy Industry. According to the research analysis, Global Liquid Biopsy Market is expected to be US$ 3.1 Billion by 2026. A liquid biopsy is an emerging tool for the diagnosis of cancer disease nowadays. The liquid biopsy involves collecting samples and analysing tumours in the blood to diagnose cancer disease in the human body. Liquid biopsy assists medical pract...
United States Laura Wood Biocept Inc Neogenomics Inc Genomic Health Office Hours Call

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Cilastatin Sodium Market Size, Share, Industry Trends, Leading Players, Market Share and Forecast 2020-2027 – Business

The global cilastatin sodium market size was accounted for USD 806 million in 2020 and expected to grow at a significant CAGR of 3.1% during the forecast period 2021 to 2027 and projected to reach over USD 990 million by 2027. The increasing incidence of lower respiratory tract infections is a primary factor to drive the market growth. On the basis of clinical application, the segment is divided into lower respiratory tract infections, urinary tract infections, and other applications. The lowe...
United States South Africa Vijendra Singh Asia Pacific Fresenius Kabi Enzo Life Sciences Inc

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science